NCT05743972

Contrast-Enhanced Ultrasound vs Conventional US-guided Percutaneous Needle Biopsy for Pancreatic Diseases: Prospective Multicenter Randomized Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 196 (estimated)
• Sponsor: xiao-yan xie · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

According to previous studies, contrast-enhanced ultrasound (CEUS) -guided Core Biopsy(GB) could improve the diagnosis of biopsy in liver and other superficial mass compared to conventional US-GB. The purpose of this randomized trial is to estimate whether CEUS-GB achieve excellent diagnostic value to conventional US-GB in percutaneous biopsy for pancreatic diseases.

Detailed description

The patients with pancreatic diseases who need receive percutaneous biopsy were randomized with 1:1 ratio into undergo CEUS-GB group and conventional US-GB group.The aims include: Comparison the diagnostic accuracy rate between CEUS and US group. Comparison the diagnostic specificity, sensitivity and complication rate between CEUS and US group.

Conditions

• Pancreatic Disease

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Contrast-enhanced ultrasound-guided core biopsy	Core biopsy was used to collect samples for pancreatic diseases under contrast-enhanced ultrasound-guided.
DIAGNOSTIC_TEST	Conventional ultrasound-guided core biopsy	Core biopsy was used to collect samples for pancreatic diseases under conventional ultrasound-guided.

Timeline

• Start date: 2023-03-01
• Primary completion: 2025-12-01
• Completion: 2026-02-01
• First posted: 2023-02-24
• Last updated: 2023-02-24

Locations

1 site across 1 country: China